| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2000;35:722.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Georgia Prevention Institute (F.A.T., R.W.J., G.K., G.A.M.), the Vascular Biology Center (J.S.P., D.M.P.), Departments of Pediatrics and Psychiatry (F.A.T.), and Office of Biostatistics (H.D.), Medical College of Georgia, Augusta, Ga.
Correspondence to Frank A. Treiber, PhD, Georgia Prevention Institute, HS 1640, Augusta, GA 30912-3710. E-mail ftreiber{at}mail.mcg.edu
| Abstract |
|---|
|
|
|---|
Key Words: endothelin stress blood pressure race young adults blacks hypertension, essential
| Introduction |
|---|
|
|
|---|
The underlying physiological mechanisms responsible for enhanced vasoconstrictive responsivity (ie, increased TPR) to stress in blacks are unknown. Endothelial cellderived vasoconstrictive and vasodilator substances are central to the regulation of vascular tone. Endothelin-1 (ET-1) is a 21-residue peptide with potent vasoconstrictive activity.12 ET-1 is expressed by endothelial cells and is primarily released basolaterally to elicit smooth muscle cell contractions.13 Therefore, circulating ET-1 may reflect only a minor portion of total ET-1 synthesis such that elevations in venous ET-1 represent spillover from large increases in ET-1 production. The systemic infusion of ET-1 in humans causes increases in BP and TPR for both normotensives and hypertensives through the potentiation of SNS activity.14 Some studies in adults, but not all,15 16 have reported higher levels of ET-1 in hypertensives compared with normotensives.17 18 Recently, adult black hypertensives were found to have considerably higher ET-1 levels than normotensive blacks and whites regardless of hypertension status.19 A second study that involved normotensive adults found that black men exhibited higher basal ET-1 levels than white men.20 Although the pathogenesis of EH has its origins in childhood,21 whether race differences in ET-1 levels at rest are present in youths has not been evaluated.
Several studies have found that ET-1 is rapidly released in response to acute physical (eg, cold pressor) and mental (eg, mental arithmetic) stress.22 23 Letizia et al24 found that borderline hypertensive adults exhibited a greater release of ET-1 in response to cold stimulation than did normotensives. Interestingly, Noll et al25 observed that ET-1 levels increased significantly more in response to mental arithmetic in adults with a positive family history of EH than in those with a negative family history. To date, the potential differential impact of race on ET-1 release during acute stress has not been examined.
The present study provided an exploratory examination of possible racial differences in vasoconstrictive function and plasma ET-1 levels at rest and in response to 2 brief laboratory stressors in normotensive males with positive family histories of EH. Individuals with positive family histories of EH are at an increased risk for the development of EH.26 Among youths with a positive family history of EH, blacks have been shown to exhibit greater vasoconstriction-mediated BP levels at rest or during acute stress than whites.10 11 Thus, an examination of ET-1 levels in multiethnic samples of youths with family histories of EH may be particularly informative regarding possible racial differences in the underlying pathophysiology of EH. Based on previous findings indicating that ET-1 mediates vasoconstrictive tone and that blacks exhibit greater vasoconstriction-mediated BP at rest and during acute stress, it was hypothesized that blacks would experience greater vascular tone concomitant with increased plasma ET-1 levels at baseline and in response to 2 acute stressors known to elicit vasoconstriction-mediated BP increases.
| Methods |
|---|
|
|
|---|
Hemodynamic Measurements
The study was approved by the institutional review committee.
After informed consent was obtained, anthropometric measurements were
performed according to established protocols.28 Subjects
were then escorted to a private, temperature-regulated room (20° to
22°C), and spot electrodes were placed for the measurement of cardiac
output with a thoracic bioimpedance system (NCCOM-3 model 6; BoMed
Medical Manufacturing, Ltd).10 Subjects were fitted with
an appropriately sized BP cuff on the right arm for use with a Dinamap
model 1846 SX automated BP monitor (Critikon). Cardiac output was
measured concomitantly with BP readings. TPR index (TPRI) was
calculated as TPRI=(1/3 systolic BP+2/3
diastolic BP [DBP])/cardiac output/body surface
area).
Blood Collection and Stress Protocol
After attachment of the electrodes and BP cuff, subjects were
asked to lie on a bed in the supine position. After the left elbow was
stabilized with an armboard, a 21-gauge butterfly needle (4492; Abbott
Laboratories) was inserted into the antecubital vein, and a 3-way
plastic stopcock was attached. Immediately after needle placement, a
5-mL blood sample was drawn, transferred to a 10-mL prechilled EDTA
tube (Vacutainer), and maintained on ice. Then, 1 mL of 0.9% saline
was infused at 1- to 3-minute intervals to maintain venous access
during the remainder of the protocol. The subject was then instructed
to relax, and 5-mL blood samples were drawn 15 and 20 minutes later
during the initial rest period. Next, a 10-minute video game (Breakout;
Atari, Inc) was presented under a monetary incentive challenge
as described previously.11 After a 20-minute recovery
period, forehead cold stimulation was conducted by placing a plastic
bag containing 1.5 cups of water and 6 cups of crushed ice on the
subjects forehead for 1 minute. Then, 5-mL blood samples were drawn,
and hemodynamics were concomitantly measured
immediately on completion of each stressor and at minutes 15 and 20
during the recovery period that followed each stressor. The forehead
cold stimulation task was presented last due to significant
variability in hemodynamic recovery
rates.10 At the end of the session, tubes were
centrifuged at 3000 rpm for 15 minutes, and plasma was stored
at -80°C.
ET-1 Measurements
Plasma ET-1 levels were determined with ELISA (QuantiGlo; R&D
Systems) according to the manufacturers instructions. The reported
cross-reactivity of the antibody was <0.02% for all big ETs, 7.8%
for ET-3, and 27.4% for ET-2. Samples were thawed at room temperature,
inverted 3 times, and centrifuged for 5 minutes at
1500g at 4°C. All samples and standards were processed in
duplicate. Unknown sample data were fitted to a standard curve with
commercially available software (Prism 2.0; GraphPad Software). At the
end of the assay, plates were covered with a yellow plastic cover (R&D
Systems), and the luminol substrate was detected with total photon
counting (TopCount; Packard). The intra-assay variability was 4.2%.
Data Analyses
Initial analyses of possible racial differences in
anthropometric and resting hemodynamics were made with
univariate ANOVAs. A series of 2x9 (racextime) repeated
measures ANOVAs were conducted with the hemodynamic
parameters and ET-1 across the evaluation periods from
catheter insert through completion of the final recovery reading. An
level of 0.05 was used. Possible race differences in reactivity to
the stressors were also examined with a series of follow-up
t tests in which change scores were computed through
subtraction of the previous resting measure from the stressor response.
One-tailed tests were used to interpret the latter findings.
| Results |
|---|
|
|
|---|
|
The repeated measures ANOVA yielded significant time and race main effects for ET-1, DBP, and TPRI (P<0.03 for all) and a significant time effect for systolic BP (P<0.001). The time effect indicated that regardless of race, subjects exhibited significant increases in ET-1, systolic BP, DBP, and TPR in response to the 2 stressors. As can be seen in the Figure, the main effect for race was such that blacks exhibited higher ET-1, DBP, and TPRI values throughout the protocol compared with whites. Post-hoc univariate ANOVAs were conducted on these parameters at each time point. Findings revealed that blacks exhibited higher ET-1 and TPRI levels at every time point during the protocol (P<0.05 for all). Blacks exhibited significantly higher levels of DBP during the video game and the subsequent initial recovery, as well as during both recovery periods after cold stimulation (P<0.04 for all).
|
Finally, the analyses involving change scores revealed that blacks exhibited significantly greater increases in ET-1 in response to both stressors (P<0.02 for both). Similarly, blacks showed trends toward greater increases in DBP, TPRI, or both in response to both stressors (P<0.07 for all).
| Discussion |
|---|
|
|
|---|
The significant increases in ET-1 in response to forehead cold stimulation corroborate previous studies in adults that used forearm cold stimulation.22 29 To our knowledge, this is the second study to indicate that ET-1 increases rapidly in response to an active behavioral challenge (ie, video game).25 Although the ET-1 responses to the stressors mirrored the increases in DBP and TPR, it is unclear whether changes in ET-1 contributed to the hemodynamic changes. Indirect support for a role of ET-1 as a mediator of BP and TPR changes is provided by the observations that ET-1 infusion in normotensive and hypertensive adults results in immediate and dose-dependent increases in DBP and TPR.14
Similar to the race differences in ET-1 levels, blacks exhibited higher levels of vasoconstrictive tone at every evaluation point. Trends were observed in which blacks exhibited greater increases in BP, vasoconstrictive tone, or both in response to the stressors, which is consistent with previous youth reactivity studies.10 11 Blacks did exhibit greater increases in ET-1 in response to the 2 stressors; reasons for the racial differences in the hemodynamic and ET-1 responses are unclear. The groups did not differ in age, height, weight, adiposity, resting BP, or family history of EH, factors that might affect SNS activity and plasma ET-1 levels. However, the nitric oxide pathway has also been shown to differ between normotensive blacks and whites. Lang et al30 identified a blunted vasodilatory response to isoproterenol in healthy blacks. Cardillo et al31 32 confirmed this observation and extended the differences in drug responsiveness in the context of mental stress in blacks. Further evidence for an upregulation of the ET system in blacks comes from a recent finding of Ergul et al33 indicating that blacks possess a higher ratio of vasoconstriction-promoting ET receptors in saphenous vein preparations.33 Thus, the synergistic effects of increased receptor bound ET-1 and reduced vasodilator responsiveness to classic vasodilators may explain the race differences in vasoconstrictive tone at rest or during acute physical or mental stress, particularly in studies involving healthy youths10 11 and young adults.8 9
Although the findings are provocative, they should be interpreted cautiously for several reasons. First, the sample consisted of youths with family histories of EH. Whether such race differences would be evident in youths without family histories of EH is unknown. Second, the sample involved only males, who have been shown to exhibit higher basal levels of ET-1 than women in adult studies.20 Again, whether similar patterns of results would be obtained with normotensive women remains to be determined. Third, whether an exaggerated release of ET-1 is responsible for greater vasoconstriction-mediated BP reactivity in blacks is unclear. Studies with ET receptor antagonists are necessary to determine whether there is a causal link between ET-1 release and BP responsivity during stress. In addition, whether exaggerated ET-1 release in response to repeated acute bouts of stress leads to early vascular remodeling and increased chronic vasoconstrictive tone is unknown but is being examined in longitudinal studies in our laboratory.
| Acknowledgments |
|---|
Received September 22, 1999; first decision October 4, 1999; accepted November 4, 1999.
| References |
|---|
|
|
|---|
2.
Svetkey LP, Timmons PZ, Emovon O, Anderson NB, Wilson
AF. Association of hypertension with ß2-
and
2c10-adrenergic receptor genotype.
Hypertension. 1996;27:12101215.
3. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948953.
4. Anderson NB, McNeilly M, Myers H. Toward understanding race difference in autonomic reactivity. In: Turner JR, Sherwood A, Light KC, eds. Individual Differences in Cardiovascular Response to Stress. New York, NY: Plenum Press; 1992:125145.
5. Light KC, Sherwood A, Turner JR. High cardiovascular reactivity to stress: A predictor of later hypertension development. In: Turner JR, Sherwood A, Light KC, eds. Individual Differences in Cardiovascular Response to Stress. New York, NY: Plenum Press; 1992:281293.
6. Manuck SB. Cardiovascular reactivity in cardiovascular disease: "once more unto the breach." Int J Behav Med. 1994;1:431.
7. Treiber FA, Davis H, Turner JR. Cardiovascular responsivity to stress and preclinical manifestations of cardiovascular disease in youth. In: Hayman L, McMahon M, Turner JR, eds. Health and Behavior in Childhood and Adolescence: Cross-Disciplinary Perspectives. New York, NY: Lawrence Erlbaum Associates, Inc. In press.
8. Saab PG, Tischenkel N, Spitzer SB, Gellman MD, Pasin RD, Schneiderman N. Race and blood pressure status influences cardiovascular responses to challenge. J Hypertens. 1991;9:249258.[Medline] [Order article via Infotrieve]
9. Light KC, Turner JR, Hinderliter AL, Sherwood A. Race and gender comparisons, I: hemodynamic responses to a series of stressors. Health Psychol. 1993;12:354365.[Medline] [Order article via Infotrieve]
10. Dysart JM, Treiber FA, Pflieger K, Davis H, Strong W. Ethnic differences in the myocardial and vascular reactivity to stress in normotensive girls. Am J Hypertens. 1994;7:1522.[Medline] [Order article via Infotrieve]
11. Treiber FA, Raunikar RA, Davis H, Fernandez T, Levy M, Strong WB. One year stability and prediction of cardiovascular functioning at rest and during laboratory stressors in youth with family histories of hypertension. Int J Behav Med. 1994;1:335353.[Medline] [Order article via Infotrieve]
12. Yanagisawa M, Kurihara H, Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411415.[Medline] [Order article via Infotrieve]
13.
Wager OF, Chirst G, Wojta J, Vierhapper H, Parzer S,
Nowotny PJ. Polar secretion of endothelin-1 by cultured
endothelial cells. J Biol Chem. 1992;267:1606616068.
14. Haynes WG, Hand MF, Johnstone HA, Padfield PL, Webb DJ. Direct and sympathetically mediated venoconstriction in essential hypertension. J Clin Invest. 1994;94:13591364.
15. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, Nunez DJ, Capper SJ, Brown MJ. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci (Colch). 1990;78:261264.[Medline] [Order article via Infotrieve]
16. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens. 1991;4:303308.[Medline] [Order article via Infotrieve]
17. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med. 1990;88:614618.[Medline] [Order article via Infotrieve]
18.
Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto
S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension
and chronic renal failure. Hypertension. 1990;15:493496.
19.
Ergul S, Parish DC, Puett D, Ergul A. Racial
differences in plasma endothelin-1 concentrations in individuals with
essential hypertension. Hypertension. 1996;28:652655.
20. Evans RR, Phillips BG, Singh G, Bauman JL, Gulati A. Racial and gender differences in endothelin-1. Am J Cardiol. 1996;78:486488.[Medline] [Order article via Infotrieve]
21. Newman WPI, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med. 1986;314:138144.[Abstract]
22. Fyhrquist F, Saijonmaa O, Metsarinne K, Tikkanen I, Rosenlof K, Tikkanen T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Commun. 1990;169:217221.[Medline] [Order article via Infotrieve]
23. Danese C, Parlapiano C, Zavattaro E, Di Prima M, Campana E, Rota C, Tonnarini G, Di Siena G, Borgia MC. ET-1 plasma levels during cold stress test in sclerodermic patients. Angiology. 1997;48:965968.
24. Letizia C, Cerci S, De Ciocchis A, DAmbrosio C, Scuro L, Scavo D. Plasma endothelin-1 levels in normotensive and borderline hypertensive subjects during a standard cold pressor test. J Hum Hypertens. 1995;9:903907.[Medline] [Order article via Infotrieve]
25.
Noll G, Wenzel RR, Schneider M, Oesch V, Binggeli C,
Shaw S, Weidmann P, Luscher TF. Increased activation of sympathetic
nervous system and endothelin by mental stress in normotensive
offspring of hypertensive parents. Circulation. 1996;93:866869.
26. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Hypertension: Pathophysiology, Diagnosis, and Management, 2 ed. New York, NY: Raven Press Publishers; 1995:6788.
27. Treiber FA, Davis H, Musante L, Raunikar RA, Strong WB, McCaffrey F, Meeks MC, Vandernoord R. Ethnicity, gender, family history of myocardial infarction, and hemodynamic responses to laboratory stressors in children. Health Psychol. 1993;12:615.[Medline] [Order article via Infotrieve]
28.
Behuke AR. Quantitative assessment of body build.
J Appl Physiol. 1961;16:960968.
29. Neri S, Bruno CM, Ierna D, Signorelli S, Pennisi G, Andreozzi GM. Endothelin-1 in arterial hypertension after cold pressor test. Int Angiol. 1997;16:269271.[Medline] [Order article via Infotrieve]
30.
Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB,
Wood M, Wood AJ. Attenuation of isoproterenol-mediated vasodilatation
in blacks. N Engl J Med. 1995;333:155160.
31.
Cardillo C, Kilcoyne CM, Cannon RO, Panza JA.
Attenuation of cyclic nucleotide-mediated smooth muscle
relaxation in blacks as a cause of racial differences in vasodilator
function. Circulation. 1999;99:9095.
32.
Cardillo C, Kilcoyne CM, Cannon RO, Panza JA. Racial
differences in nitric oxide-mediated vasodilator response to mental
stress in the forearm circulation. Hypertension. 1998;31:12351239.
33. Ergul A, Tackett RL, Puett D. Distribution of endothelin receptors in saphenous veins of African Americans: implications of racial differences. J Cardiovasc Pharmacol. 1999;34:327332.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
Y. Yoshida, A. Hachiya, P. Sriwiriyanont, A. Ohuchi, T. Kitahara, Y. Takema, M. O. Visscher, and R. E. Boissy Functional analysis of keratinocytes in skin color using a human skin substitute model composed of cells derived from different skin pigmentation types FASEB J, September 1, 2007; 21(11): 2829 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Angelo, J. S. Pollock, and D. M. Pollock In vivo evidence for endothelin-1-mediated attenuation of {alpha}1-adrenergic stimulation Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1251 - H1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Tharaux, I. Hagege, S. Placier, M. Vayssairat, A. Kanfer, R. Girot, and J.-C. Dussaule Urinary endothelin-1 as a marker of renal damage in sickle cell disease Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2408 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Angelo, J. S. Pollock, and D. M. Pollock Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETA receptor Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1829 - H1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Elmarakby, E. D. Loomis, J. S. Pollock, and D. M. Pollock NADPH Oxidase Inhibition Attenuates Oxidative Stress but Not Hypertension Produced by Chronic ET-1 Hypertension, February 1, 2005; 45(2): 283 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Campia, C. Cardillo, and J. A. Panza Ethnic Differences in the Vasoconstrictor Activity of Endogenous Endothelin-1 in Hypertensive Patients Circulation, June 29, 2004; 109(25): 3191 - 3195. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xiang, R. Denver, M. Bailey, and H. Krum Physiologic Determinants of Endothelin Concentrations in Human Saliva Clin. Chem., December 1, 2003; 49(12): 2012 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Treiber, P. Barbeau, G. Harshfield, H.-S. Kang, D. M. Pollock, J. S. Pollock, and H. Snieder Endothelin-1 Gene LYS198ASN Polymorphism and Blood Pressure Reactivity Hypertension, October 1, 2003; 42(4): 494 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Blascovich, W. B. Mendes, J. Tomaka, K. Salomon, and M. Seery The Robust Nature of the Biopsychosocial Model Challenge and Threat: A Reply to Wright and Kirby Personality and Social Psychology Review, August 1, 2003; 7(3): 234 - 243. [Abstract] [PDF] |
||||
![]() |
F. A. Treiber, G. K. Kapuku, H. Davis, J. S. Pollock, and D. M. Pollock Plasma Endothelin-1 Release During Acute Stress: Role of Ethnicity and Sex Psychosom Med, September 1, 2002; 64(5): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Mangiafico, L. S. Malatino, T. Attina, R. Messina, and C. E. Fiore Exaggerated Endothelin Release in Response to Acute Mental Stress in Patients with Intermittent Claudication Angiology, July 1, 2002; 53(4): 383 - 390. [Abstract] [PDF] |
||||
![]() |
A. L. Grubbs, M. P. Anstadt, and A. Ergul Saphenous Vein Endothelin System Expression and Activity in African American Patients Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1122 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kelsey, S. M. Patterson, M. Barnard, and B. S. Alpert Consistency of Hemodynamic Responses to Cold Stress in Adolescents Hypertension, December 1, 2000; 36(6): 1013 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ergul Hypertension in Black Patients : An Emerging Role of the Endothelin System in Salt-Sensitive Hypertension Hypertension, July 1, 2000; 36(1): 62 - 67. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |